c) Lipid derived autocoids and platelet activating factor
Curriculum Unit: 7. Pharmacology of autocoids and their antagonists:
Overview & Academic Context
This study module covers "Lipid derived autocoids and platelet activating factor", an integral component of the Year 2 Doctor of Pharmacy (Pharm.D) curriculum under Pharmacology-I (Pharmacology of autocoids and their antagonists). Designed for clinical pharmacy scholars, the syllabus emphasizes mechanistic understanding, clinical relevance, and high-yield examination competencies.
Core Study Concepts
Learning Objectives
Upon reviewing this syllabus topic, Pharm.D students are expected to demonstrate proficiency in:
- Understand the foundational etiology, classification, and clinical significance of Lipid derived autocoids and platelet activating factor.
- Analyze the underlying pathophysiology and disease manifestations relevant to Pharmacology of autocoids and their antagonists.
- Evaluate evidence-based pharmacotherapeutic management, therapeutic drug choices, and dosage individualization.
- Identify critical patient monitoring parameters, adverse drug reactions (ADRs), and drug-drug interactions.
Unlock Complete Interactive Notes for Lipid derived autocoids and platelet activating factor
Access clinical pathophysiology flowcharts, high-yield treatment algorithms, dose adjustment tables, AMBOSS-style search, interactive self-assessment quizzes, and board-exam mnemonics.
Curriculum References & Recommended Texts
Standard literature and institutional sources for Pharmacology-I:
- [1]Pharmacy Council of India (PCI) Pharm.D Curriculum Syllabus Guidelines
- [2]Goodman & Gilman's: The Pharmacological Basis of Therapeutics (Brunton et al.)
- [3]Rang & Dale's Pharmacology (Humphrey P. Rang et al.)
- [4]Casarett & Doull's Toxicology: The Basic Science of Poisons